PPC for aesthetics and skin clinics companies in the UK

Why does the headline that books your most popular treatment keep getting rejected, reworded, or quietly flagged by someone else in the industry before it’s even spent a tenner? Not because the offer’s weak. Because the word doing the actual selling, the brand name of the injectable, is the one word you’re not allowed to put in front of the public.

That’s the trap most clinics fall into, and it’s expensive in a way that doesn’t show up as a disapproval notice. An ad can clear Google’s review process cleanly, run for six weeks, book out the injector’s diary, and still land the clinic a formal Advertising Standards Authority ruling once a competitor or a member of the public complains. By then the campaign’s been live, the budget’s been spent, and the practice manager is explaining to the clinical director why the clinic’s name is sitting in a published ASA adjudication next to the words “likely to mislead.”

Here’s the part most PPC guides skip: the Committee of Advertising Practice Code is explicit that prescription-only medicines cannot be advertised to the public, and botulinum toxin injectables fall squarely in that category. That single rule reshapes almost every decision in a clinic’s Google Ads account, from which treatments get their own campaign to what the landing page is allowed to promise. Get the account built around that rule from the start and you can advertise aggressively, fill the consult book, and never get near an ASA complaint. Get it wrong and you’re rebuilding the account mid-quarter while last month’s ads are still being cited in a ruling.

What has to be true before you touch the keyword planner

Most clinics start a PPC build by writing ad copy. That’s backwards for this industry. The first job is sorting your own treatment menu into two piles, because each one needs a completely different advertising approach.

Pile one: treatments involving a prescription-only medicine, meaning botulinum toxin under any brand (Botox, Azzalure, Bocouture) and any prescription-only filler or adjunct a prescriber uses. These cannot be named, priced, or promised results for in a public-facing ad, full stop. Pile two: everything that isn’t a POM, which usually includes HIFU, laser hair removal, chemical peels, microneedling, skin boosters that don’t require a prescription, and most dermal fillers (fillers are typically classed as medical devices, not POMs, though claims still need to be accurate and not misleading). Pile two can be advertised far more directly, including price, before-and-after context within CAP guidelines, and named treatment.

Before a single campaign goes live, get these in place:

• A clinician-reviewed claims list, agreed with whoever holds prescribing responsibility, covering exactly what can and can’t be said about each treatment.

• Separate landing pages for POM-adjacent treatments versus non-POM treatments, because they need different copy, different proof, and different conversion paths.

• A conversion action in GA4 that tracks booked and attended consults, not just form submissions or calls answered.

• A way to feed attended-consult data back into Google Ads, because optimising toward form fills alone trains the algorithm to chase enquiries that never show up.

• Clarity on deposit policy, since no-shows are the quiet budget-killer in this category and the ad account needs to know the difference between a lead and a kept appointment.

Skip this step and every later step just gets you to disapproval, or worse, an approved ad that’s still non-compliant.

Building a Google Ads account that respects CAP and still fills the diary

This is the actual build. Each step below assumes you’ve done the sorting work above.

If a dedicated PPC build is more than your team has hours for this quarter, a partner running Google Ads management for clinics day to day can absorb the weekly disapproval review and the campaign structure work so it doesn’t fall to whoever has a free afternoon.

Where aesthetics PPC accounts get suspended or quietly starve

Picture a two-site clinic group in the West Midlands running one campaign across both locations, with ad copy that named the injectable brand directly because “everyone searches for it that way.” The ads performed well for two months. Then a rival clinic filed an ASA complaint, the ruling was upheld, and the clinic had to pull the campaign, rewrite every asset around consultation language, and rebuild its landing pages from scratch, all while the published ruling sat online for anyone researching the clinic to find. The fix wasn’t complicated once they made it: campaigns split by treatment category, copy that sold the consult rather than the drug, and a landing page per group that matched what the ad promised. What cost them wasn’t the rebuild. It was the eight weeks of reputational cleanup that followed a ruling they could have avoided entirely.

This is also where the landing page itself starts to matter as much as the ad. A compliant headline that lands on a page without clear proof, a simple booking path, or an obvious next step still loses the click. Tools like HeyLead Insights show exactly where someone scrolls, hesitates, or abandons a consult form on that page, which is far more useful than guessing why a compliant, well-targeted campaign still isn’t converting at the rate it should.

What clinic managers hear right after an ASA complaint lands

“Owner, two-site aesthetics clinic: ‘The ad had been running for weeks before anyone told us there was a problem. We’d assumed Google’s approval meant we were in the clear. It doesn’t mean that at all.’”

“Practice manager, skin and injectables clinic: ‘Patients don’t ask us what the drug’s called. They ask what the consultation involves, how long results last, and whether it hurts. The ad copy that gets them to book is never the copy that would’ve got us in trouble.’”

FAQs

Can we advertise botulinum toxin treatments on Google Ads in the UK at all? You can advertise the consultation and the service around it. You cannot advertise the prescription-only medicine itself, which means no brand names, no per-unit pricing, and no specific result claims tied to the injectable in public-facing ad copy.

Does passing Google’s ad review mean we’re compliant with ASA and CAP rules? No. Google’s review and the Advertising Standards Authority’s rules are two separate systems. An ad can run successfully on Google and still be the subject of a complaint and an upheld ruling months later.

Should we use before-and-after photos in our ads? For non-prescription treatments, carefully handled before-and-afters within CAP guidelines are generally fine. For POM-adjacent treatments, pairing imagery with implied results is where most complaints originate, so keep that imagery and language well away from each other.

What should our primary Google Ads conversion action actually be? Booked consult as the main signal, with attended consult imported as a secondary offline conversion. Counting form fills alone trains your bidding to chase enquiries, not people who show up.

Is Meta or Google better for this kind of clinic? Most clinics need both, but the compliance rules apply across every platform equally. The channel is less important than making sure the claims list and landing pages are built once, correctly, and reused everywhere.

Putting it to work

Start this week by pulling every live ad and landing page for your POM-adjacent treatments and reading them the way the ASA would: does any headline, bit of copy, or image name the drug, quote a price for it, or promise a specific result? That review takes about an hour for a typical clinic’s account and tells you immediately whether you’re exposed to a complaint right now, not six weeks from now.

If untangling campaign structure from compliance risk while still keeping the consult diary full feels like more than one person can carry alongside the rest of the clinic’s marketing, a partner who’s built this exact kind of account before can take the weekly review, the landing page rebuild, and the consult tracking off your plate. Chat with us on WhatsApp.